Percentage of people survival rate. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Cell Line, Tumor Cells, Cultured Bile Ducts, Intrahepatic Lymph Nodes Liver Cell Line Lung

Organisms7

Mice, Inbred C57BL Mice, Inbred BALB C Mice, Knockout Mice, Transgenic Swine Rats, Sprague-Dawley Cattle

Diseases56

Neoplasm Recurrence, Local Lung Neoplasms Liver Neoplasms Adenocarcinoma Lymphatic Metastasis Breast Neoplasms Carcinoma, Hepatocellular Carcinoma, Squamous Cell Disease Progression Recurrence Neoplasm Metastasis Postoperative Complications Stomach Neoplasms Carcinoma, Non-Small-Cell Lung Neoplasms Colorectal Neoplasms Neoplasm Invasiveness Brain Neoplasms Pancreatic Neoplasms Esophageal Neoplasms Disease Models, Animal Carcinoma Bone Neoplasms Bile Duct Neoplasms Melanoma Rectal Neoplasms Heart Arrest Sarcoma Cholangiocarcinoma Kidney Failure, Chronic Ovarian Neoplasms Chronic Disease Head and Neck Neoplasms Kidney Neoplasms Body Weight Prostatic Neoplasms Prosthesis Failure Acute Disease Osteosarcoma Skin Neoplasms Lymphoma, Non-Hodgkin Nasopharyngeal Neoplasms Glioblastoma Colonic Neoplasms Liver Failure Carcinoma, Small Cell HIV Infections Cadaver Mouth Neoplasms Carcinoma, Renal Cell Multiple Myeloma Glioma Hodgkin Disease Precursor Cell Lymphoblastic Leukemia-Lymphoma Soft Tissue Neoplasms Leukemia, Myeloid, Acute

Chemicals and Drugs28

Tumor Markers, Biological Antineoplastic Agents Cisplatin Cyclophosphamide Doxorubicin Vincristine Fluorouracil Prednisone Etoposide Immunosuppressive Agents Antibodies, Monoclonal Deoxycytidine Antimetabolites, Antineoplastic RNA, Messenger Vinblastine Methotrexate Paclitaxel Carboplatin Cryoprotective Agents Bleomycin Neoplasm Proteins Cytarabine Tumor Suppressor Protein p53 Proto-Oncogene Proteins Dacarbazine Ki-67 Antigen Recombinant Proteins Biological Markers

Analytical, Diagnostic and Therapeutic Techniques and Equipment104

Survival Rate Survival Analysis Disease-Free Survival Treatment Outcome Retrospective Studies Prognosis Follow-Up Studies Kaplan-Meier Estimate Neoplasm Staging Combined Modality Therapy Proportional Hazards Models Antineoplastic Combined Chemotherapy Protocols Risk Factors Multivariate Analysis Prospective Studies Cohort Studies Immunohistochemistry Actuarial Analysis Chemotherapy, Adjuvant Liver Transplantation Registries Risk Assessment Incidence Predictive Value of Tests Hepatectomy Radiotherapy, Adjuvant Drug Administration Schedule Analysis of Variance Reoperation Kidney Transplantation Life Tables Radiotherapy Dosage Chi-Square Distribution Remission Induction Disease Models, Animal Regression Analysis Severity of Illness Index Questionnaires Lymph Node Excision Cause of Death Transplantation, Homologous Prevalence Patient Selection Neoadjuvant Therapy Probability Gastrectomy Cryopreservation SEER Program Cardiopulmonary Resuscitation Cross-Sectional Studies Chemoembolization, Therapeutic Reproducibility of Results Radiotherapy Random Allocation Statistics, Nonparametric Salvage Therapy Logistic Models Case-Control Studies Treatment Failure Dose Fractionation Reverse Transcriptase Polymerase Chain Reaction Palliative Care Randomized Controlled Trials as Topic Chemoradiotherapy Body Weight Clinical Trials as Topic Prosthesis Failure Feasibility Studies Longitudinal Studies Pneumonectomy Esophagectomy Pilot Projects Radiotherapy, High-Energy Neoplasm Grading Tomography, X-Ray Computed Blotting, Western Preoperative Care Brachytherapy Risk Mortality Life Expectancy Drug Therapy, Combination Sensitivity and Specificity Models, Biological Tumor Burden Transplantation, Autologous Renal Dialysis Prosthesis Design Gene Expression Profiling Heart Transplantation Pancreas Transplantation Infusions, Intravenous Cell Count Odds Ratio Dose-Response Relationship, Radiation Immunoenzyme Techniques Postoperative Care Hematopoietic Stem Cell Transplantation Leukocyte Count Confidence Intervals Bone Marrow Transplantation Activities of Daily Living Breeding Amputation

Psychiatry and Psychology1

Phenomena and Processes32

Cell Survival Graft Survival Time Factors Apoptosis Chi-Square Distribution Graft Rejection Signal Transduction Dose-Response Relationship, Drug Cell Proliferation Probability Pregnancy Gene Expression Regulation, Neoplastic Mutation Aging Tissue Survival Body Weight Risk Microbial Viability Phenotype Sensitivity and Specificity Longevity Cell Division Cell Differentiation Cell Count Odds Ratio Dose-Response Relationship, Radiation Drug Resistance, Neoplasm Leukocyte Count Genotype Cell Death Gene Expression Breeding

Disciplines and Occupations2

Immunohistochemistry Outcome Assessment (Health Care)

Anthropology, Education, Sociology and Social Phenomena6

Survival Age Distribution Quality of Life Sex Distribution Socioeconomic Factors Activities of Daily Living

Humanities1

Quality of Life

Information Science11

Survival Rate Registries Incidence Life Tables Questionnaires Cause of Death Prevalence SEER Program Mortality Life Expectancy Databases, Factual

Named Groups5

Infant, Newborn Tissue Donors Survivors Living Donors European Continental Ancestry Group

Health Care60

Survival Rate Survival Analysis Disease-Free Survival Treatment Outcome Retrospective Studies Follow-Up Studies Kaplan-Meier Estimate Proportional Hazards Models Risk Factors Multivariate Analysis Prospective Studies Cohort Studies Age Factors Actuarial Analysis Registries Risk Assessment Incidence Predictive Value of Tests Sex Factors Analysis of Variance Life Tables Chi-Square Distribution Regression Analysis Severity of Illness Index Questionnaires Cause of Death Prevalence Age Distribution Patient Selection Probability SEER Program Cross-Sectional Studies Reproducibility of Results Random Allocation Statistics, Nonparametric Logistic Models Case-Control Studies Treatment Failure Sex Distribution Palliative Care Randomized Controlled Trials as Topic Socioeconomic Factors Clinical Trials as Topic Feasibility Studies Longitudinal Studies Comorbidity Pilot Projects Preoperative Care Risk Mortality Outcome Assessment (Health Care)Life Expectancy Sensitivity and Specificity Healthy People Programs Odds Ratio Dose-Response Relationship, Radiation Postoperative Care Confidence Intervals Activities of Daily Living Tissue and Organ Procurement

Geographicals12

United States Japan China Great Britain England France Europe Italy Australia Taiwan Canada Netherlands

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Survival Rate Cell Survival Survival Analysis Disease-Free Survival Treatment Outcome Retrospective Studies Survival Graft Survival Time Factors Prognosis Follow-Up Studies Kaplan-Meier Estimate Neoplasm Staging Combined Modality Therapy Proportional Hazards Models Antineoplastic Combined Chemotherapy Protocols Neoplasm Recurrence, Local Risk Factors Multivariate Analysis Lung Neoplasms Prospective Studies Liver Neoplasms Adenocarcinoma Cohort Studies Apoptosis Age Factors Lymphatic Metastasis Tumor Markers, Biological Immunohistochemistry Actuarial Analysis Antineoplastic Agents Chemotherapy, Adjuvant Breast Neoplasms Liver Transplantation Carcinoma, Hepatocellular Registries Carcinoma, Squamous Cell Risk Assessment Cisplatin Disease Progression Recurrence Neoplasm Metastasis United States Incidence Postoperative Complications Predictive Value of Tests Stomach Neoplasms Hepatectomy Sex Factors Radiotherapy, Adjuvant Carcinoma, Non-Small-Cell Lung Drug Administration Schedule Cyclophosphamide Doxorubicin Vincristine Cell Line, Tumor Analysis of Variance Reoperation Neoplasms Fluorouracil Japan Kidney Transplantation Colorectal Neoplasms Neoplasm Invasiveness Brain Neoplasms Life Tables Mice, Inbred C57BL Pancreatic Neoplasms Radiotherapy Dosage Esophageal Neoplasms Chi-Square Distribution Remission Induction Infant, Newborn Disease Models, Animal Carcinoma Graft Rejection Regression Analysis Signal Transduction Severity of Illness Index Questionnaires Lymph Node Excision Cause of Death Transplantation, Homologous Dose-Response Relationship, Drug Cells, Cultured Cell Proliferation Prevalence China Age Distribution Patient Selection Tissue Donors Quality of Life Neoadjuvant Therapy Probability Gastrectomy Prednisone Pregnancy Cryopreservation Mice, Inbred BALB C Bone Neoplasms

No FAQ available that match "percentage of people survival rate"